These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 9930628)

  • 1. Indices of carbohydrate and lipid metabolism in vasopressin-replete and -deficient New Zealand genetically hypertensive rats.
    Al-Barazanji KA; Buckingham RE; Balment RJ
    Horm Metab Res; 1998 Dec; 30(12):717-20. PubMed ID: 9930628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormalities of carbohydrate and lipid metabolism in patients with hypertension.
    Fuh MM; Shieh SM; Wu DA; Chen YD; Reaven GM
    Arch Intern Med; 1987 Jun; 147(6):1035-8. PubMed ID: 3296980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin kinetic, glucose tolerance, and lipid metabolism in genetically spontaneous-hypertensive rats.
    Baumann R; Moritz V; Gödicke W; Postnow JW; Ziegler M
    Acta Biol Med Ger; 1976; 35(6):K 33-9. PubMed ID: 983618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of red blood cell ion transport alterations and serum lipid abnormalities in Lyon genetically hypertensive rats.
    Zicha J; Dobesová Z; Kunes J; Vincent M
    Can J Physiol Pharmacol; 1997 Sep; 75(9):1123-8. PubMed ID: 9365824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Alteration of blood glucose, insulin and lipid in the offsprings of patients with essential hypertension].
    Yang T; Sun M; Zhou H; Xie X
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(1):37-40. PubMed ID: 11938735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signs of attenuated depression-like behavior in vasopressin deficient Brattleboro rats.
    Mlynarik M; Zelena D; Bagdy G; Makara GB; Jezova D
    Horm Behav; 2007 Mar; 51(3):395-405. PubMed ID: 17258216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cathepsin L immunoreactivity in the hypothalamus of normal, streptozotocin-diabetic and vasopressin-deficient Brattleboro rats.
    Bernstein HG; Roskoden T; Kirschke H; Hahn HJ; Wiederanders B; Novakova V
    Cell Mol Biol (Noisy-le-grand); 1994 Mar; 40(2):159-64. PubMed ID: 8003946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrasting metabolic effects of antihypertensive agents.
    Velliquette RA; Ernsberger P
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1104-11. PubMed ID: 14557373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasopressin gene expression in hypertensive, normotensive, and diabetes insipidus rats.
    McCabe JT; Almasan K; Lehmann E; Hänze J; Lang RE; Pfaff DW; Ganten D
    Clin Exp Hypertens A; 1988; 10 Suppl 1():131-42. PubMed ID: 3242986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertension and CHD: evidence of glucose and lipid metabolism involvement.
    Clemenzia G; Amoroso A; Gubitosi G; Cavarretta LM; Vaccaro F; Ferri GM
    Riv Eur Sci Med Farmacol; 1996; 18(3):105-11. PubMed ID: 9177606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of manidipine and delapril on glucose and lipid metabolism in hypertensive patients with non-insulin-dependent diabetes mellitus.
    Atarashi K; Takagi M; Minami M; Kimura Y; Matsuoka H; Sugimoto T
    Blood Press Suppl; 1992; 3():130-4. PubMed ID: 1343282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High blood pressure and metabolic disorders are associated in the Lyon hypertensive rat.
    Vincent M; Boussaïri EH; Cartier R; Lo M; Sassolas A; Cerutti C; Barrès C; Gustin MP; Cuisinaud G; Samani NJ
    J Hypertens; 1993 Nov; 11(11):1179-85. PubMed ID: 8301098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular, renal, and endocrine responses to low-dose atrial natriuretic peptide in the fluid-balanced New Zealand genetically hypertensive rats with and without endogenous arginine vasopressin.
    Abu-Amarah I; Balment RJ
    Can J Physiol Pharmacol; 1999 Feb; 77(2):102-10. PubMed ID: 10535700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma and lipoprotein lipid composition and hepatic antioxidant status in spontaneously hypertensive (SHR) and normotensive (WKY) rats.
    Kitts DD; Yuan YV; Godin DV
    Can J Physiol Pharmacol; 1998 Feb; 76(2):202-9. PubMed ID: 9635161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weight reduction versus antihypertensive drug therapy in obese men with high blood pressure: effects upon plasma insulin levels and association with changes in blood pressure and serum lipids.
    Fagerberg B; Berglund A; Andersson OK; Berglund G
    J Hypertens; 1992 Sep; 10(9):1053-61. PubMed ID: 1328365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of celiprolol on insulin sensitivity and glucose tolerance in dyslipidemic hypertension.
    Malminiemi K; Lahtela JT; Huupponen R
    Int J Clin Pharmacol Ther; 1995 Mar; 33(3):156-63. PubMed ID: 7599914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitrendipine and metabolic balance.
    Ferrara LA; Marotta T
    J Cardiovasc Pharmacol; 1991; 18 Suppl 5():S19-21. PubMed ID: 1725797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood pressure and renal function in a novel vasopressin-deficient, genetically hypertensive rat strain.
    Ashton N; Balment RJ
    J Physiol; 1989 Mar; 410():21-34. PubMed ID: 2795478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormalities of insulin and lipid metabolism in Milan hypertensive rats.
    Dall'Aglio E; Tosini P; Ferrari P; Zavaroni I; Passeri M; Reaven GM
    Am J Hypertens; 1991 Sep; 4(9):773-5. PubMed ID: 1930861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma lipids in genetically hypertensive rats of the Lyon strain.
    Sassolas A; Vincent M; Benzoni D; Sassard J
    J Cardiovasc Pharmacol; 1981; 3(5):1008-14. PubMed ID: 6168846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.